Gene Logic to Establish UK-Based Subsidiary - Gene Logic Ltd
Continues Expansion of Global Pharmacogenomics Services with EU Staff
"Europe is a key part of our international strategy, evidenced by the group of European pharmaceutical companies who are current customers, including AstraZeneca, Aventis, Boehringer Ingelheim, GlaxoSmithKline and Novartis," said Mark D. Gessler, Chairman and CEO of Gene Logic. "This new Gene Logic initiative enables us to forge a closer working relationship with this portion of our international customer base. In getting closer to our existing customers we will be able to learn more about their needs and apply our expanded services as solutions to their ongoing research and development needs."
The new Gene Logic European operation will begin with local dedicated sales and marketing personnel. Neil Hocking has been hired as Gene Logic's Executive Director for Business Development in Europe and comes to the Company with nineteen years experience in the pharmaceutical, healthcare and life sciences industries at various companies, including SANYO, MDL and Celera Genomics.
"Over the coming months we will bring on additional sales and support personnel as needed," commented Larry Tiffany, Vice President of International Business Development for Gene Logic. "We're pleased to have Neil join Gene Logic and are looking forward to having him help us expand our European customer base, strengthen ties with our customers and build our Business Development organization."
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.